Cargando…

Third doses of SARS-CoV-2 vaccines in immunosuppressed patients with inflammatory bowel disease

Detalles Bibliográficos
Autores principales: Alexander, James L, Selinger, Christian P, Powell, Nick
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier Ltd. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8511687/
https://www.ncbi.nlm.nih.gov/pubmed/34653395
http://dx.doi.org/10.1016/S2468-1253(21)00374-5
_version_ 1784582819705520128
author Alexander, James L
Selinger, Christian P
Powell, Nick
author_facet Alexander, James L
Selinger, Christian P
Powell, Nick
author_sort Alexander, James L
collection PubMed
description
format Online
Article
Text
id pubmed-8511687
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Published by Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-85116872021-10-13 Third doses of SARS-CoV-2 vaccines in immunosuppressed patients with inflammatory bowel disease Alexander, James L Selinger, Christian P Powell, Nick Lancet Gastroenterol Hepatol Correspondence Published by Elsevier Ltd. 2021-12 2021-10-13 /pmc/articles/PMC8511687/ /pubmed/34653395 http://dx.doi.org/10.1016/S2468-1253(21)00374-5 Text en Crown Copyright © 2021 Published by Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Correspondence
Alexander, James L
Selinger, Christian P
Powell, Nick
Third doses of SARS-CoV-2 vaccines in immunosuppressed patients with inflammatory bowel disease
title Third doses of SARS-CoV-2 vaccines in immunosuppressed patients with inflammatory bowel disease
title_full Third doses of SARS-CoV-2 vaccines in immunosuppressed patients with inflammatory bowel disease
title_fullStr Third doses of SARS-CoV-2 vaccines in immunosuppressed patients with inflammatory bowel disease
title_full_unstemmed Third doses of SARS-CoV-2 vaccines in immunosuppressed patients with inflammatory bowel disease
title_short Third doses of SARS-CoV-2 vaccines in immunosuppressed patients with inflammatory bowel disease
title_sort third doses of sars-cov-2 vaccines in immunosuppressed patients with inflammatory bowel disease
topic Correspondence
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8511687/
https://www.ncbi.nlm.nih.gov/pubmed/34653395
http://dx.doi.org/10.1016/S2468-1253(21)00374-5
work_keys_str_mv AT alexanderjamesl thirddosesofsarscov2vaccinesinimmunosuppressedpatientswithinflammatoryboweldisease
AT selingerchristianp thirddosesofsarscov2vaccinesinimmunosuppressedpatientswithinflammatoryboweldisease
AT powellnick thirddosesofsarscov2vaccinesinimmunosuppressedpatientswithinflammatoryboweldisease
AT thirddosesofsarscov2vaccinesinimmunosuppressedpatientswithinflammatoryboweldisease